Gaush Meditech Ltd (HKG:2407)

Hong Kong · Delayed Price · Currency is HKD

4.910

-0.130 (-2.58%)

Jun 18, 2026, 3:55 PM HKT

-22.06% (1Y)

Market Cap	703.74M -21.0%
Revenue (ttm)	1.54B -3.4%
Net Income	107.04M +4.1%
EPS	0.74 +6.0%
Shares Out	143.33M
PE Ratio	6.66
Forward PE	n/a
Dividend	0.30 (6.11%)
Ex-Dividend Date	Jun 23, 2025

Volume	38,000
Open	4.880
Previous Close	5.040
Day's Range	4.550 - 5.150
52-Week Range	4.460 - 9.990
Beta	0.02
Analysts	Hold
Price Target	16.79 (+241.55%)
Earnings Date	Aug 28, 2026

About Gaush Meditech

Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company’s product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refrac... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1998

Employees 893

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2407

Full Company Profile

Financial Performance

In 2025, Gaush Meditech's revenue was 1.38 billion, a decrease of -3.36% compared to the previous year's 1.43 billion. Earnings were 96.19 million, an increase of 4.11%.

Financial numbers in CNY Financial Statements